| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |